- ABOUT US
- LIVE TRAINING
- TOOLS & RESOURCES
Mr. Kastango received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. He completed 65 hours of training in nuclear pharmacy at Purdue University and 80 hours of didactic training for the Six Sigma-Green Belt certification that he started with BD Medical Systems.
Eric received a coveted ISMP Cheers Award in 2015 for his work related to sterile compounding safety. He is one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award that recognized his efforts and assistance to the states and NABP to address the compounding tragedy that occurred in 2012.
Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.
He is an active member and Fellow of the American Society of Healthcare Pharmacists and served on the USP Sterile Compounding Committee from 2005-2010 and 2010-2015 USP Council of Experts, Compounding Expert Committee until April 2013. In May 2013, USP recognized Eric and the members of Compounding Expert Committee with an Award for Outstanding Contribution to the USP Standards-Setting Process.
He has served on the USP Hazardous Drug Expert Panel since 2010. He is actively working with NABP and state boards of pharmacy to provide training to their sterile compounding inspectors. Eric served on the Expert Panel for ASHP Research & Education Foundation in the development of the 2015 Outsourcing Sterile Products Preparation Vendor Assessment Tool and ASHP’s Insourcing Readiness Assessment Tool.
He is also the author of the 2004 ASHP Discussion Guide on Sterile Preparation: Summary and Implementation of USP Chapter 797, the ASHP Sterile Product Preparation CD-ROM: A Multimedia Learning Tool, the ASHP web-based 797 Compliance Advisor Gap Analysis Tool for USP Chapter 797. He assisted in the development of the CriticalPoint web-based educational series on Sterile Compounding and the Annual National USP <797> Compliance Survey now in its fifth year. Eric has over 200 invited national and international professional presentations on various pharmacy practice topics such as pharmacy compounding, patient safety and quality systems.
Kate Douglass is the Vice President and Chief Development Officer of CriticalPoint, LLC, a healthcare training and development company. She is a co-author of CriticalPoint’s Interactive USP Chapter 797 and 800 Gap Analysis Tools and Co-Director of the USP Sterile Compounding Compliance Study. Kate has written numerous articles on sterile compounding quality and training. She co-authored a paper commissioned by the Pew Charitable Trust titled “Quality Standards for Large-Scale Sterile Compounding Facilities” and is the senior member of the Sterile Compounding Boot Camp Live Training Series Faculty. Kate has personally supervised the design, engineering, and build of pharmacy compounding facilities that met or exceeded USP requirements. She was the Project Manager for the design and build of CriticalPoint’s Center for Training and Research in Totowa, New Jersey.
Before joining CriticalPoint, Kate was the President of Performance Strategies, LLC; a company focused on best practice sterile compounding and drug administration assisting hospitals, alternate site, manufacturing, and commercial health care market segments. Kate has also served as the Senior VP of Clinical Operations for Coram Healthcare and as COO of SoluNet, LLC, a licensed pharmacy and FDA-registered manufacturer (later acquired by B. Braun’s CAPS) that provided CSPs to hospitals. Licensed as an Advanced Practice Nurse, Kate received her Bachelor of Science from Villanova University and an MS from Rutgers, The State University of New Jersey. She also holds a post graduate Certificate in Advanced E-Learning Instructional Design.
Patricia Kienle is the Director of Accreditation and Medication Safety for Cardinal Health Innovative Delivery Solutions.
She received her pharmacy degree from the Philadelphia College of Pharmacy and Science, and a Masters in Public Administration from Marywood University in Scranton, Pennsylvania. She completed an Executive Fellowship in Patient Safety from Virginia Commonwealth University and is an Adjunct Associate Professor at Wilkes University in Wilkes-Barre, Pennsylvania.
She has served on the Board of Directors of the American Society of Health-System Pharmacists and as President of the Pennsylvania Society of Hospital Pharmacists. She is a Fellow of ASHP, was named Pharmacist of the Year by PSHP, and the recipient of the Distinguished Achievement Award in Hospital and Institutional Practice from the American Pharmaceutical Association Academy of Pharmacy Practice and Management, and the Distinguished Leadership Award from ASHP. She has served on the Pharmacotherapy Specialty Council of the Board of Pharmaceutical Specialties, the Pennsylvania Patient Safety Authority, the Hospital Professional and Technical Advisory Committee of The Joint Commission, and on the Board of Governors of the National Patient Safety Foundation. She is a current member of the USP Compounding Expert Committee and chairs the Subcommittee on Hazardous Drugs.
Patti is the author of Compounding Sterile Preparations: ASHP’s Visual Guide to Chapter <797> video and Companion Guide, co-author of Assuring Continuous Compliance with Joint Commission Standards: A Pharmacy Guide, 8th edition, and author of The Chapter <800> Answer Book. She edited Understanding JCAHO Requirements for Hospital Pharmacies.
She is a frequent presenter to professional groups, with special interests in promoting medication safety, compounding sterile preparations, accreditation, and regulatory issues.
Mark is Director of Special Projects for Clinical IQ and a pharmacist with over 30 years’ experience in sterile compounding: hospital, infusion therapy/home and LTC, as well as, FDA regulated outsourcing facilities. Mark’s main focus through the years was the introduction and instillation of GCP/ GMP culture through quality systems management of SOP development, documentation, training and CAPA.
Joseph W. Coyne RPh currently serves as the Director of Field Operations for Clinical IQ where has been since 2017. In his current role he acts as a trusted source for pharmacy information services and product solutions for clients who range from local start-up operations to established national organizations in the hospital, home care, and specialty compounding industries. Prior to joining forces with the Clinical IQ team, Joe served as President and CEO of Coyne Consulting and before that he served as the Enterprise Vice-President of Pharmacy Services for Cancer Treatment Centers of America (CTCA).
Joe has practiced pharmacy in many different capacities and settings, including hospitals, community-based retail, long-term care, hospice and home care.
Joe is a trusted speaker who has been invited to present nationally and internationally on various pharmacy practice topics such as; pharmacy compounding, hazardous drug handling, and quality standards. He has presented at the local, state and national levels to State Pharmacy and Hospital Associations, National Society meeting and for Fortune 500 companies. He is also currently serving as a faculty member at the CriticalPoint Center for Training and Research (CCTR) presenting on the topics of hazardous drug handling and aseptic preparation. CCTR’s mission is to increase patient safety by delivering engaging educational programming that results in a measurable change in performance in the areas of sterile compounding.
Joe continues to contribute to numerous industry publications including ASHP’s Compounding Sterile Preparations, 4th Edition which he co-authored the Hazardous Drug Handling Chapter, and is co-authoring the ASHP Hazardous Drug Handling Technician Bulletin revision. He is also an active member of the American Society of Healthcare Pharmacists (ASHP) and has served on the Board of Directors for several organizations including an International Compounding Organization.
Joe received his Bachelor of Science degree in pharmacy from the Philadelphia College of Pharmacy and Science where he served as s Clinical Preceptor and an Adjunct Senior Clinical Professor of the Department of Pharmacy Practice. He lives in Illinois with his family and when not working in the pharmacy community or with his family, you will find him on the road satisfying his passion for bike riding.
Melanie Dorey, RPhT, is licensed in Canada as a Pharmacy Technician. She graduated from La Cite Collegiale from a two-year Pharmacy Technician program that is specialized in sterile compounding in 2006. She has been working as a technician at a pediatric hospital since 2006. Melanie also has served as an aseptic teacher (practical and theory) at an accredited pharmacy technician college in Ottawa since 2010. Melanie has been working with CriticalPoint since 2015. She is currently the lead Aseptic Instructor at CriticalPoint and runs a 1-and-a-half-day class, which includes lectures and hands-on learning and competencies in aseptic technique. Melanie is QP503A certified and serves as a subject matter expert for CriticalPoint for other areas such as nonsterile compounding development of standard operating procedures and elearning, pharmacy math, hazardous compounding, video shoots, and editing, as well as eCurriculum development. She also works with CriticalPoint’s sister company, KCG, as an aseptic consultant and offsite speaker. She travels to different sites to offer hands-on training and lectures on many different subjects, including but not limited to cleaning, disinfecting, aseptic technique, hand hygiene and garbing, environmental monitoring, and compounder conduct. Melanie shares knowledge and theories to help make improvements in current work practices. She also assists facilities with developing and completing evaluations/competencies. Melanie has performed a variety of roles at the pediatric hospital (which she is still employed on a casual basis). These roles include tech check tech, IV Room lead, critical care technician, writing and reviewing standard operating procedures, medication reconciliation, pharmacy buyer, billing, research/study technician, as well as performing as a preceptor to new employees. She has joined NAPRA on a Review Committee for Compounding Competencies voluntarily. Melanie has a passion for sharing knowledge and loves teaching the “why” behind the “how.”
Michelle Martin is a certified pharmacy technician who is licensed with the Massachusetts Board of Pharmacy. In addition, she is a Certified Sterile Products Technician through PTCB and has earned her QP503A™ designation through CriticalPoint, LLC.
Michelle has spent most of her career as a sterile compounding technician and brings with her a passion for educating others about best compounding practices. She has performed sterile compounding in a variety of settings including manufacturing, hospital and home infusion. Michelle is a preceptor for the Institutional Pharmacy Practice Lab at the Massachusetts College of Pharmacy and Health Sciences where she teaches pharmacy students sterile compounding practices. At CriticalPoint, Michelle works with other CriticalPoint subject matter experts to provide engaging live training.
Mary Nazzal, PharmD, is the Associate Director of Field Operations for Clinical IQ LLC. She received her PharmD degree from Butler University of Indianapolis and has completed the Nuclear Pharmacy Certificate Program at Purdue University. She has over 14 years of progressive and diverse hospital pharmacist experience including administrative, inpatient pharmacy, de-centralized pharmacy, operating room with a focus in Sterile Compounding. Prior to joining Clinical IQ in 2017, Mary established and lead Sterile Compounding Services including pharmacy related policy/procedure/SOP development, technology setup and implementation, training development and implementation for Cleveland Clinic, Abu Dhabi in the United Arab Emirates.
Greg has over 14 years of sterile compounding experience in both pharmacy and manufacturing. He has operated two 503B Outsourcing Facilities and has assisted organizations in navigating multiple FDA inspections. Greg has considerable experience in all facets of running an FDA compliant compounding facility including formulation development, cGMP gap analysis and remediating 483 observations.
Abby Roth is the Senior Director of Business Operations at CriticalPoint, LLC, a health care training and development company. In her current role she assists in making decisions for operational activities and set strategic goals and plans and monitors the day-to-day running of the business to ensure progress. In addition, she develops curriculum for CriticalPoint’s elearning modules and live training classes. She is also a faculty member for the Sterile Compounding Boot Camp Live Training Series which includes but is not limited to environmental monitoring programs, contamination control practices and sanitization programs. Prior to joining CriticalPoint, Abby served as the Director of Microbiology for Clinical IQ, LLC, and as a Quality Director at a contract microbiology laboratory specializing in environmental monitoring and product testing.
Abby has over 16 years of experience in supporting the testing and consulting needs of the pharmaceutical, medical device and compounding industries. Her background in pharmaceutical microbiology includes extensive knowledge of environmental monitoring, including program development, sampling technique, sample analysis and data trending. Abby also has experience in consulting on microbial contamination sources and remediation. She holds a Bachelor of Science degree in Biology and a minor in Chemistry from York College of Pennsylvania. In 2014, she became a Certified Manager of Quality/Organizational Excellence through the American Society of Quality.
She served as an expert committee member for the USP Compounding Committee from 2015 to 2019 and is an involved member of Controlled Environment Testing Association (CETA), speaking at their annual meeting and participating in the revision of their CETA Application Guides. Additionally, she has been invited to speak at the state and national level.
Adam West is the Environmental Monitoring and Training Specialist at CriticalPoint, LLC. In his current role he is responsible for the development of live training curriculum and eLearning modules for Field Certification Technicians seeking to advance their skills, reinforce fundamental knowledge and implement best practices for the certification of controlled environments.
Adam has over 10 years of experience in the certification industry providing Field Certification Services for 503A and 503B sterile compounding facilities and pharmaceutical and medical device manufacturers. In addition to certification, he has extensive knowledge in viable environmental monitoring, including sampling plan development and remediation. Adam has also provided consultation services for USP Chapter <797> facility compliance. Adam holds the Registered Cleanroom Certification Professional – Sterile Compounding Facilities (RCCP-SCF) certification and NSF-49 accreditation.